Acute Porphyria
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP) (NCT03505853) | Alnylam Pharmaceuticals | 2018-04-26 |
| ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP) (NCT03338816) | Alnylam Pharmaceuticals | 2017-11-16 |
Track Acute Porphyria automatically
Every clearance here is in the API, with alerts when new ones post.